ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CLOV vs CELC // GROSS PROFIT MARGIN

Clover Health Investments Corp. (Class A) (NASDAQ) VS. Celcuity Inc. (NASDAQ) • 15-METRIC TALLY: CLOV 3 — CELC 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLOV VS. CELC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CLOV CELC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -29.30% -35.00% +5.70 CLOV /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -2.84% -4.53% +1.69 CLOV /fcf-yield <GO>
Operating Margin -4.40% — — TIE /operating-margins <GO>
Net Profit Margin -4.40% — — TIE /net-margins <GO>
Revenue Growth (YoY) 40.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.62 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 CLOV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.3 49.3 -4.01 CELC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.43B $3.39B -$958.3M CELC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CLOV REV CELC REV CLOV GROSS % CELC GROSS % CLOV FCF CELC FCF
FY 2025 $1.92B $0 — — -$69.0M -$153.5M
FY 2024 $1.37B $0 — — $33.3M -$83.7M
FY 2023 $1.26B $0 — — -$144.7M -$53.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLOV // BETA —
CELC // BETA —